| Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) | 
|---|
| 04/09/2003 | EP1299362A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof | 
| 04/09/2003 | EP1299094A2 Selective androgen receptor modulators and methods for their identification, design and use | 
| 04/09/2003 | EP1058711B1 Bicyclooctane derivatives as plasticisers | 
| 04/09/2003 | EP0984962B1 Substituted 4-benzoyl-pyrazoles | 
| 04/09/2003 | EP0892793B1 Substituted tetracyclic tetrahydrofuran derivatives | 
| 04/09/2003 | EP0873123B1 Inhibitors of protein isoprenyl transferases | 
| 04/09/2003 | CN1409714A Pentacycle taxane compounds | 
| 04/09/2003 | CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds | 
| 04/09/2003 | CN1105113C Fungicidal pyrimidinones | 
| 04/08/2003 | US6545166 Process for producing spiro acetal derivative | 
| 04/08/2003 | US6545151 Pentacyclic compound | 
| 04/03/2003 | WO2003027120A1 Continuous ozonolysis of cycloalkenes into ozonides | 
| 04/03/2003 | WO2003027119A1 Isosorbide derivatives | 
| 04/03/2003 | US20030065018 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof | 
| 04/03/2003 | US20030064985 Prevent virus reproduction | 
| 04/03/2003 | US20030064982 Pyrazole compounds useful as protein kinase inhibitors | 
| 04/03/2003 | US20030064981 Anticancer agents; antidiabetic agents; Alzheimer's disease | 
| 04/03/2003 | US20030064117 For oral administration, injection and topical application | 
| 04/02/2003 | EP1296989A2 Polycyclic xanthones as antibiotics | 
| 04/02/2003 | EP1015446B1 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents | 
| 04/02/2003 | CN1407987A Hexahydrofuro'2,3-Blfuran-3-yl-N-´¢ø3'(1,3-benzodioxol-5-ylsulfonyl)(isobutyl) Aminol-1-benzyl-2-hydroxypropyl´¢Øcarbamate as retroviral protease inhibitor | 
| 04/02/2003 | CN1407979A Fluorescent probes for quantitation of zinc | 
| 04/02/2003 | CN1406941A 1,2,4,5-pyromellitic anhydride preparation | 
| 04/02/2003 | CN1104502C Genes encoding branched-chain alpha-Ketoacid dehydrogenase complex from streptomyces avermitilis | 
| 04/01/2003 | US6541655 Catalytic compositions and methods for asymmetric allylic alkylation | 
| 03/27/2003 | WO2003025638A1 Oxygen-containing heterocyclic fused naphthopyrans | 
| 03/27/2003 | WO2003025070A2 Polymeric articles comprising novel bismethine benzodifuranone derivative colorants | 
| 03/27/2003 | WO2003024975A1 Laulimalide-derivatives, their use and process for the production of laulimalide and laulimalide-derivatives | 
| 03/27/2003 | WO2003024974A2 Process for preparing protease inhibitor intermediates | 
| 03/27/2003 | WO2002026220A3 Taxoid conjugates as antimitotic and antitumor agents | 
| 03/27/2003 | US20030060623 Having microtubule-stabilizing effects and cytotoxic activity against rapidly proliferating cells, such as, tunior cells or other hyperproliferative cellular disease | 
| 03/26/2003 | EP1295886A1 Laulimalide-derivates, their use and process for the production of laulimalide and laulimalide-derivates | 
| 03/26/2003 | EP1294727A2 Continuous process for the manufacture of anhydro sugar alcohols | 
| 03/26/2003 | EP1114043B1 Naphthopyrans annelated in c 6?-c 7?, their preparation and compositions and (co)polymer matrices containing them | 
| 03/26/2003 | EP1098893B1 Cyclic compounds useful in the treatment of dyslipidemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process | 
| 03/26/2003 | EP1021432B1 Halogen substituted tetracyclic tetrahydrofuran derivatives | 
| 03/26/2003 | EP0977748B1 Substituted benzopyran derivatives for the treatment of inflammation | 
| 03/26/2003 | CN1405168A Tert-butoxy carbonyl dihydro artemisinin, preparation method and drug composition thereof | 
| 03/26/2003 | CN1405165A Method for preventing oxidation of ginkgo leaf extractive | 
| 03/26/2003 | CN1405164A Corter pseudolaricis acid derivatives, preparation method and use thereof | 
| 03/26/2003 | CN1103776C Chiral dopants and liquid crystal material and polymer film comprising it | 
| 03/26/2003 | CN1103766C Novel taxoids, preparation thereof and pharmaceutical compositions containing same | 
| 03/25/2003 | US6537999 Pyrimidine derivatives and methods of making and using these derivatives | 
| 03/25/2003 | CA2071717C Antipsychotic benzodioxan derivatives | 
| 03/20/2003 | WO2003022994A2 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto | 
| 03/20/2003 | WO2003022855A1 Tert-butoxy dihydro artimisinin, its production and pharmaceutical composition | 
| 03/20/2003 | WO2003022854A1 A substituted furochromenone derivative exhibiting anti-cancer and anti-proliferative properties | 
| 03/20/2003 | WO2003022853A1 Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol | 
| 03/20/2003 | WO2003022844A2 Synthesis of epothilones intermediates thereto and analogues thereof | 
| 03/20/2003 | WO2002098363A3 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM | 
| 03/20/2003 | WO2002088136A3 Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene | 
| 03/20/2003 | US20030055089 Endoparasiticidal and ectoparasiticidal agents | 
| 03/20/2003 | US20030055072 Methods of inhibiting Pin1-associated states using a fredericamycin a compound | 
| 03/20/2003 | US20030055068 Pyrazole compounds useful as protein kinase inhibitors | 
| 03/20/2003 | US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient | 
| 03/20/2003 | US20030052305 Thermochromic liquid crystalline medium encapsulated in a light transmissive polymeric material, useful in decorative applications, cosmetics, thermodiagnostic and security applications | 
| 03/20/2003 | CA2459168A1 Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol | 
| 03/19/2003 | EP1292597A1 Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them | 
| 03/19/2003 | EP1292275A1 Ferulic ester derivative, 3,9-diferulylcoumestrol and cosmetic product containing same | 
| 03/19/2003 | EP1138679B1 HYDRONAPHTHO 2,3-c]FURAN DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF | 
| 03/19/2003 | EP1077980B1 Epothilone derivatives, a method for the production thereof, and their use | 
| 03/19/2003 | EP0799228B1 3-aryl-tetronic acid derivatives, the production thereof and the use thereof as anti-parasitic agents | 
| 03/19/2003 | CN1403462A Supercritical fluid extraction process of barbasco compounds | 
| 03/19/2003 | CN1403461A Microwave extraction process of barbasco compounds | 
| 03/18/2003 | WO2002024712A1 Triazolo-epothilones | 
| 03/18/2003 | US6534434 Chiral imidazolidinone-based catalyst composition and reaction system | 
| 03/18/2003 | US6534041 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy | 
| 03/18/2003 | US6533825 Dibenzonaphthyrones | 
| 03/18/2003 | CA2422500A1 Triazolo-epothilones | 
| 03/13/2003 | WO2003021228A2 Heteroaryl substituted benzothiazole dioxetanes | 
| 03/13/2003 | WO2003020725A1 Coumarin compounds | 
| 03/13/2003 | WO2003020714A1 Polyester polycarbonates made from special diphenols | 
| 03/13/2003 | WO2003020264A1 Remedial agent for cancer and cancer preventive | 
| 03/13/2003 | WO2002076385A3 Asymmetric benzaldehyde alditol derivatives, methods of making thereof, and compositions and articles containing same | 
| 03/13/2003 | WO2002074291A3 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor | 
| 03/13/2003 | US20030050495 4'-alkyl,6'-(protected hydroxy),7'-hydroxy-spiro(cyclopropane-1,5'-hexahydroindan-2,3 a(4),7a(1)-triene) compound of given formula, intermediate to illudin analogs of the mushroom Omphalotus illudens | 
| 03/13/2003 | US20030050485 Tricyclic and tetracyclic taxane intermediates | 
| 03/13/2003 | US20030050343 Novel potentiating compounds | 
| 03/13/2003 | US20030049230 Methods for protection of plants from Oomyocyte pathogens by use of Serratia marcescens and isolates | 
| 03/13/2003 | CA2459918A1 Heteroaryl substituted benzothiazole dioxetanes | 
| 03/12/2003 | EP1036058B1 Adamantane derivatives | 
| 03/12/2003 | EP0983287B1 Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions | 
| 03/12/2003 | CN1402729A Polycycloalkylpurines as adenosine receptor antagonists | 
| 03/11/2003 | US6531497 Epothilone derivatives and their synthesis and use | 
| 03/11/2003 | CA2099543C Photochemical labelling of nucleic acids with digoxigenin reagents and their use in gene probe test systems | 
| 03/06/2003 | WO2003018591A1 Novel pseudolaric acid-b derivatives, their preparation and pharmaceutical compositions | 
| 03/06/2003 | WO2003018574A1 Rapamycin dialdehydes | 
| 03/06/2003 | WO2003018573A1 Rapamycin 29-enols | 
| 03/06/2003 | WO2003018535A2 Novel aminobenzoephenones | 
| 03/06/2003 | WO2003018521A1 Substituted alkene diols | 
| 03/06/2003 | US20030045714 Photochromic sections being 2H-pyrans and/ or spirooxazines; use in ophthalmic lenses or sun-protection roofs | 
| 03/06/2003 | US20030045516 Chemokine receptor antagonists and methods of use therefor | 
| 03/06/2003 | CA2455311A1 Rapamycin dialdehydes | 
| 03/06/2003 | CA2455308A1 Rapamycin 29-enols | 
| 03/05/2003 | EP1288186A2 Vinyl ether compounds and preparation process thereof | 
| 03/05/2003 | EP1287000A1 Method for purifying a composition containing at least an internal dehydration product for a hydrogenated sugar | 
| 03/05/2003 | EP1226134B1 Naphthopyrans having a perfluoroalkyl substituent in position 5, preparation and compositions containing them | 
| 03/05/2003 | EP1185534B1 Benzopyrans annelated in c7-c8 with an aromatic heterocycle and compositions and (co)polymer matrices containing them | 
| 03/05/2003 | EP1109549B1 Analgesic use of podophyllotoxin for treating pain conditions in female genital organs | 
| 03/05/2003 | EP0874851B1 Macrocyclic compounds made from carbon suboxide units |